APOTHEEK INGE VERMEIREN
ActiveAPOTHEEK INGE VERMEIREN has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €328k and a net result of €6k. Equity is growing by ~20.7% per year across the filed fiscal years. Its solvency ranks better than 70% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
74
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability70▼-17
Solvency82▼-3
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €24k at 30 days acceptable
Liquidity ample (current ratio 4.57 against 6.66 in 2024; short-term debt: 18.4% and cash: 13.2% of total assets), and 42.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
57.4%
Return on assets
1.1%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
29 d late
2023
29 d late
2022
31 d late
2021
31 d late
2020
2 d late
2019
34 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€328k▲ 2.0%
2024 · €322k
2018: €73k
2019: €103k
2020: €130k
2021: €188k
2022: €173k
2023: €243k
2024: €322k
2018 → 2025
Total assets
€571k▲ 5.9%
2024 · €540k
2018: €197k
2019: €397k
2020: €472k
2021: €494k
2022: €516k
2023: €461k
2024: €540k
2018 → 2025
Net result
€6k▼ 91.8%
2024 · €79k
2018: €1k
2019: €30k
2020: €27k
2021: €58k
2022: €61k
2023: €69k
2024: €79k
2018 → 2025
Working capital
€375k▲ 4.6%
2024 · €358k
2018: €73k
2019: €21k
2020: €119k
2021: €191k
2022: €191k
2023: €271k
2024: €358k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€188k-€173k▼ 7.6%€243k▲ 39.8%€322k▲ 32.6%€328k▲ 2.0%
Operating result€78k-€84k▲ 7.6%€95k▲ 14.1%€108k▲ 13.2%€11k▼ 89.5%
Net result€58k-€61k▲ 5.4%€69k▲ 13.9%€79k▲ 14.4%€6k▼ 91.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 90% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €571k
Fixed assets
€92k▼ 22.3%
Current assets
€480k▲ 13.8%
Equity and liabilities €571k
Equity
€328k▲ 2.0%
Debt
€243k▲ 11.6%
The debt ratio rises from 40.4% to 42.6%. Equity and debt are higher.
Key figures and ratios
EBITDA
€40k▼
2024 · €136k
Cash flow
€35k▼
2024 · €107k
Solvency
57.4%▼
2024 · 59.6%
Current ratio
4.57▼
2024 · 6.66
Quick ratio
2.81▼
2024 · 3.82
Debt / equity
0.74▲
2024 · 0.68
ROE
2.0%▼
2024 · 24.6%
ROA
1.1%▼
2024 · 14.6%
Interest coverage
8.09▼
2024 · 30.70
Debt
€243k▲
2024 · €218k
Debt ≤ 1 year
€105k▲
2024 · €63k
Debt > 1 year
€137k▼
2024 · €154k
Income taxes
€3k▼
2024 · €26k
Staff costs
€120k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€540k€571k▲
Fixed assets21/28€118k€92k▼
Tangible fixed assets22/27€118k€92k▼
Plant, machinery and equipment23€29k€22k▼
Furniture and vehicles24€88k€69k▼
Current assets29/58€422k€480k▲
Stocks and contracts in progress3€179k€185k▲
Stocks30/36€179k€185k▲
Amounts receivable within one year40/41€177k€208k▲
Trade receivables40€52k€74k▲
Other amounts receivable41€124k€133k▲
Cash at bank and in hand54/58€57k€75k▲
Deferred charges and accrued income490/1€8k€12k▲
Equity and liabilities
Total equity and liabilities10/49€540k€571k▲
Equity10/15€322k€328k▲
Contributions10/11€19k€19k=
Reserves13€303k€309k▲
Distributable reserves133€303k€309k▲
Amounts payable17/49€218k€243k▲
Amounts payable after more than one year17€154k€137k▼
Financial debts170/4€154k€137k▼
Amounts payable within one year42/48€63k€105k▲
Current portion of amounts payable after more than one year42€17k€17k=
Trade debts44€45k€61k▲
Suppliers440/4€45k€61k▲
Taxes, remuneration and social security45€1k€24k▲
Taxes450/3€1k€2k▲
Remuneration and social security454/9-€22k
Other amounts payable47/48€20€4k▲
Accrued charges and deferred income492/3€441€906▲
Income statement
Code20242025
Remuneration, social security and pensions62-€120k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€28k€28k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€449€2k▲
Other operating charges640/8€781€801▲
Gross operating margin9900€137k€162k▲
Operating profit (loss)9901€108k€11k▼
Financial income75/76B€2k€3k▲
Recurring financial income75€2k€3k▲
Financial charges65/66B€4k€5k▲
Recurring financial charges65€4k€5k▲
Profit (loss) for the period before taxes9903€105k€9k▼
Income taxes67/77€26k€3k▼
Profit (loss) for the period9904€79k€6k▼
Profit (loss) for the period to be appropriated9905€79k€6k▼
Appropriation of the result
Profit (loss) to be appropriated9906€79k€6k▼
Transfer to equity691/2€79k€6k▼
To other reserves6921€79k€6k▼
Social balance
Average headcount (FTE)9087-1.2
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 31 days late
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 29 days late
2024
31-12
Financial
Highest result since 2018net €79k ▲14.4%
Operating result €108k, net result €79k, both a record.
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 29 days late
2023
31-12
Financial
Liquidity triplescurrent ratio 6.77
Current ratio from 2.23 to 6.77; short-term debt falls from €155k to €47k.
31-12
Financial
Equity above €200kEq €243k ▲39.8%
6 profitable years in a row build equity to €243k.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 31 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 31 days late
2021
31-12
Financial
Equity above €150kEq €188k ▲44.2%
4 profitable years in a row build equity to €188k.
02-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 2 days late
2020
03-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 34 days late
2019
31-12
Financial
Equity above €100kEq €103k ▲40.5%
2 profitable years in a row build equity to €103k.
08-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 8 days late
2018
16-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 16 days late
2017
14-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 14 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Koksijde · 1 establishment unit since 2009
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Zeelaan(Kok) 2878670 KoksijdeGround area
339 m²
Building footprint
269 m²
Volume, LiDAR
3,393 m³
Parcel 38014E0401/00A000, Flanders · tallest building 17.5 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
BV APOTHEEK INGE VERMEIREN
since 20092.175.524.215
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 38014E0401/00A000 | Flanders | 339 m² | 1 · 269 m² | 17.5 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteKoksijde2.175.524.215
Similar companies · same sector, comparable size
APOTHEEK VAL-MEER
BE 0718.796.526
Riemst · Eq €328k
MEER APOTHEEK
BE 0431.364.245
Hoogstraten · Eq €328k
PHARMACIE SIXTINE BRUNELLI
BE 0729.811.172
Braine-l'Alleud · Eq €328k
APOTHEEK VANDEPUTTE PHARMACIE
BE 0438.291.629
Spiere-Helkijn · Eq €328k
PHARMACIE DE MERBES
BE 0809.241.504
Merbes-le-Château · Eq €327k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,484 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded26-12-2008
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers
Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.